| Lobbyist Public Search |
|
Records prior to registration year 2005 are not available online.
Contact the Lobbyist Division here for assistance.
|
Search data is collected from registration records and disclosure reports
submitted by lobbyists, lobbying entities, and their clients. Massachusetts General Law requires any party providing or retaining
lobbying services to register annually, and submit disclosure reports twice a year.
|
| Your comments are welcome:
submit feedback
|
|
| Disclosure reporting details |
|
Back to search detail summary
|
|
:
01/01/2021 - 06/30/2021
|
|
Authorizing Officer name
|
Martin
G.
Corry
|
|
Title
|
Principal
|
|
Business name
|
Corry Associates, LLC
|
|
Address
|
6 Beacon Street
Suite 312
|
|
City, state, zip code
|
Boston, MA 02108
|
|
Country
|
US
|
|
Phone
|
617-227-2345
|
|
|
|
|
Client Compensation
|
| Massachusetts Nurses Association |
$45,000.00
|
| Motion Picture Association, Inc. |
$100,000.00
|
| Sanofi US, Inc. |
$37,500.00
|
| AstraZeneca Pharmaceuticals LP |
$100,000.00
|
| Harness Horseman's Association of New England |
$33,000.00
|
| Beer Distributors of Massachusetts, Inc. |
$85,000.00
|
| Massachusetts State Automobile Dealers Association |
$18,000.00
|
| Cape Cod Chamber of Commerce & CVB |
$20,000.00
|
| Total salaries received |
$438,500.00
|
|
|
| |
|
Compensation/Salaries Paid
|
|
Martin G. Corry
|
$140,000.00
|
|
Dominique Salogar
|
$37,000.00
|
|
Charles Anthony Stefanini
|
$64,500.00
|
| Total salaries paid |
$241,500.00
|
|
| |
|
Activities, Bill Numbers and Titles
|
| No activities, bill numbers or bill titles were disclosed for this reporting period. |
|
| |
|
Operating Expenses
|
| No operating expenses were filed for this disclosure reporting period. |
|
| |
|
Meals, Travel, and Entertainment Expenses
|
| No meals, travel, or entertainment expenses were filed for this disclosure reporting period. |
|
| |
|
Additional Expenses
|
| No additional expenses were filed for this disclosure reporting period. |
|
| |
|
Campaign Contributions
|
| No campaign contributions were filed for this disclosure reporting period. |
|
| |
|
Lobbyist: Charles Anthony Stefanini
|
|
Client:
AstraZeneca Pharmaceuticals LP
|
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $0.00
|
|
Executive
|
Massachusetts Health Policy Commission (HPC)
|
Promoted and assisted with information pertaining to the HPC study on the use of prescription drug coupons and vouchers. Interactions (virtual) with the HPC and participation in the HPC Advisory Council quarterly meetings (virtually). Participate in public meetings/discussions pertaining to drug costs (net and gross) and value-based contracts with health plans as well as MassHealth. Promoted the overall clinical value of prescription medicines and the economic impact of the biotechnology sector in the Commonwealth of MA.
|
Support
|
$0.00
|
n/a
|
|
Senate Bill
|
771
|
An Act relative to pharmaceutical access, costs and transparency
|
Oppose
|
$0.00
|
n/a
|
|
House Bill
|
1311
|
An Act relative to step therapy and patient safety
|
Support
|
$0.00
|
n/a
|
|
House Bill
|
1247
|
An Act to ensure more affordable care
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
1191
|
An Act to help patients and reduce health care costs by ensuring patient adherence to medications
|
Support
|
$0.00
|
n/a
|
|
Senate Bill
|
1915
|
An Act to eliminate the tax deduction for direct-to-consumer pharmaceutical marketing
|
Oppose
|
$0.00
|
n/a
|
|
House Bill
|
1137
|
An Act relative to cancer patient access to biomarker testing to provide appropriate therapy
|
Support
|
$0.00
|
n/a
|
|
Senate Bill
|
804
|
An Act to promote transparency and prevent price gouging of pharmaceutical drug prices
|
Oppose
|
$0.00
|
n/a
|
|
Senate Bill
|
808
|
An Act relative to cancer patient access to biomarker testing to provide appropriate therapy
|
Support
|
$0.00
|
n/a
|
|
Executive
|
Massachusetts Health Policy Commission (HPC)
|
Direct involvement with the State’s HPC as a formal member of the HPC Advisory Council in discussions to implement the MA Health Care Cost Containment Law (Chapter 224). Discussions with the HPC and/or Advisory Council and Center for Health Information & Analysis (CHIA) with a focus on health care price variation, gross and net Rx drug costs to the state, as well as the establishment and implementation of Accountable Care Organizations (ACO’s). My interactions are with HPC Board Members, HPC Staff to include Executive Director, and the staff from CHIA.
|
Neutral
|
$0.00
|
n/a
|
|
Senate Bill
|
644
|
An Act relative to consumer deductibles
|
Support
|
$0.00
|
n/a
|
|
Senate Bill
|
790
|
An Act to define modest meals and refreshments in prescriber education settings
|
Oppose
|
$0.00
|
n/a
|
|
Senate Bill
|
756
|
An Act relative to step therapy and patient safety
|
Support
|
$0.00
|
n/a
|
|
Senate Bill
|
697
|
An Act relative to insurance coverage for mammograms and breast cancer screening
|
Neutral
|
$0.00
|
n/a
|
|
Executive
|
Massachusetts Health Policy Commission (HPC)
|
Engaged in the Health Policy Commission (HPC) Drug Pricing Review Process and the Standard Reporting Form. Specifically the process for determining valuation of Rx drugs, transparency reporting requirements and rebate negotiations.
|
Oppose
|
$0.00
|
n/a
|
|
Executive
|
Other
|
Engaged in discussions with members of the Executive and Legislative branches concerning the development and potential rollout of AstraZeneca’s COVID-19 vaccine. As of the filing of this report, AstraZeneca’s vaccine has yet to be approved by the Food & Drug Administration (FDA). Thus, these discussions were for planning purposes only in the event the vaccine was approved. Specifically on COVID vaccine, members of the Legislative House COVID-19 Working Group. These topics pertained to the progress of clinical trials, distribution, and supply. Engaged on various COVID-19 current Executive Orders to ensure compliance with our essential workers in MA. Specifically Executive Order# 53 pertaining to stay-at-home advisory, business capacities and early closures and capacities (order #54) and face coverings (Order #55). Engaged in discussions related to the proposed rules for 101 CMR 801.00 and proposed drug pricing review regulations 958 CMR 12.00.
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
1
|
An Act making appropriations for the Fiscal Year 2022 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the Commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements
|
Oppose
|
$0.00
|
n/a
|
|
House Bill
|
1053
|
An Act relative to consumer deductibles
|
Support
|
$0.00
|
n/a
|
|
Senate Bill
|
785
|
An Act to improve the accessibility and affordability of pharmaceutical drugs of public health concern
|
Oppose
|
$0.00
|
n/a
|
|
House Bill
|
4000
|
An Act making appropriations for the fiscal year 2022 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Oppose
|
$0.00
|
n/a
|
|
Senate Bill
|
728
|
An Act relative to pharmaceutical gag clauses
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
1201
|
An Act ensuring access to medications
|
Support
|
$0.00
|
n/a
|
|
Senate Bill
|
1480
|
An Act to prevent undue influence on prescriber behavior
|
Oppose
|
$0.00
|
n/a
|
|
House Bill
|
1254
|
An Act relative to promoting comprehensive transparency in the pharmaceutical industry
|
Oppose
|
$0.00
|
n/a
|
|
Senate Bill
|
3
|
An Act making appropriations for the fiscal year 2022 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Oppose
|
$0.00
|
n/a
|
|
House Bill
|
1237
|
An Act relative to non-medical switching
|
Support
|
$0.00
|
n/a
|
|
Senate Bill
|
1481
|
An Act to restore integrity in the marketing of pharmaceutical products and medical devices
|
Oppose
|
$0.00
|
n/a
|
|
Senate Bill
|
696
|
An Act to help patients and reduce healthcare costs by ensuring patient adherence to medications
|
Support
|
$0.00
|
n/a
|
|
House Bill
|
1175
|
An Act relative to the diagnosis and treatment of breast cancer
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
2377
|
An Act to permit the wholesale importation of prescription drugs into the Commonwealth
|
Oppose
|
$0.00
|
n/a
|
|
Senate Bill
|
1465
|
An Act to reduce healthcare costs by promoting non-biased prescriber education
|
Oppose
|
$0.00
|
n/a
|
| | | |
Total amount
|
$0.00
| |
|
|
Lobbyist: Charles Anthony Stefanini
|
|
Client:
Cape Cod Chamber of Commerce & CVB
|
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $0.00
|
|
House Docket
|
1336
|
Administrative costs
|
Support
|
$0.00
|
n/a
|
|
Senate Docket
|
1792
|
Timily - allocation of funds
|
Support
|
$0.00
|
n/a
|
|
House Docket
|
401
|
Timily - allocation of funds
|
Support
|
$0.00
|
n/a
|
|
Senate Docket
|
1803
|
Tourism recovery
|
Support
|
$0.00
|
n/a
|
| | | |
Total amount
|
$0.00
| |
|
|
|
|
Meals, Travel, and Entertainment Expenses
|
| No meals, travel, or entertainment expenses were filed for this disclosure reporting period. |
|
| |
|
Additional Expenses
|
| No additional expenses were filed for this disclosure reporting period. |
|
| |
|
Campaign Contributions
|
| No campaign contributions were filed for this disclosure reporting period. |
|
|
Lobbyist: Dominique Salogar
|
|
Client:
Beer Distributors of Massachusetts, Inc.
|
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $0.00
|
|
House Bill
|
343
|
An Act relative to the sale of liquor licenses
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
364
|
An Act relative to the sale of alcoholic beverages
|
Neutral
|
$0.00
|
n/a
|
|
Senate Bill
|
179
|
An Act to update the alcohol excise tax
|
Neutral
|
$0.00
|
n/a
|
|
Senate Bill
|
1921
|
An Act relative to the taxation of cider
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
26
|
An Act modernizing the Massachusetts alcohol laws
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
338
|
An Act further regulating storage of alcoholic beverages
|
Neutral
|
$0.00
|
n/a
|
|
Senate Bill
|
169
|
An Act restoring happy hour to the commonwealth
|
Neutral
|
$0.00
|
n/a
|
|
Senate Bill
|
2215
|
An Act to create a deposit for glass wine and liquor bottles
|
Neutral
|
$0.00
|
n/a
|
|
Senate Bill
|
2159
|
An Act relative to the proper disposal of miniatures
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
374
|
An Act for all licensees for beer to be drunk on the premises must list the alcohol by volume for each beer selection on the menu
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
320
|
An Act relative to licensure of equine dentists
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
315
|
An Act relative to municipal millennials
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
362
|
An Act relative to alcoholic beverage containers
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
373
|
An Act relative to notification of alcohol by volume in beers to be consumed on the premises
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
318
|
An Act relative to the sale of wines and malt beverages by food stores
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
397
|
An Act expanding access to craft beer
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
344
|
An Act further regulating storage of alcoholic beverages
|
Neutral
|
$0.00
|
n/a
|
|
Senate Bill
|
168
|
An Act relative to the creation of additional business opportunities for alcohol retailers
|
Neutral
|
$0.00
|
n/a
|
| | | |
Total amount
|
$0.00
| |
|
|
Lobbyist: Dominique Salogar
|
|
Client:
Coalition of Families and Advocates - COFAR
|
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $0.00
|
|
Senate Bill
|
1257
|
An Act establishing a commission on the history of state institutions for people with developmental and mental health disabilities in the Commonwealth
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
193
|
An Act regarding transparency for individuals and guardians
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
1733
|
An Act further regulating the appointment of certain guardians
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
2090
|
An Act establishing a special commission to study and report on the history of state institutions for people with developmental and mental health disabilities in the Commonwealth
|
Neutral
|
$0.00
|
n/a
|
| | | |
Total amount
|
$0.00
| |
|
|
Lobbyist: Dominique Salogar
|
|
Client:
Massachusetts Nurses Association
|
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $0.00
|
|
House Bill
|
1255
|
An Act relative to hospital profit transparency and fairness
|
Neutral
|
$0.00
|
n/a
|
|
Senate Bill
|
253
|
An Act relative to PPE data transparency
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
1253
|
An Act relative to the closing of hospital essential services
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
496
|
An Act relative to PPE data transparency
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
2249
|
An Act relative to safe patient handling and mobility in certain health facilities
|
Neutral
|
$0.00
|
n/a
|
|
Senate Bill
|
754
|
An Act relative to the closing of hospital essential services
|
Neutral
|
$0.00
|
n/a
|
|
Senate Bill
|
1310
|
An Act relative to creating intensive stabilization and treatment units within the Department of Mental Health
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
2465
|
An Act requiring health care employers to develop and implement programs to prevent workplace violence
|
Neutral
|
$0.00
|
n/a
|
|
Senate Bill
|
1603
|
An Act requiring health care facilities to develop and implement programs to prevent workplace violence
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
1888
|
An Act relative to strengthening the penalty for assault or assault and battery on an emergency medical technician, ambulance operator, ambulance attendant or health care provider
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
2706
|
An Act relative to credible service for school nurses
|
Neutral
|
$0.00
|
n/a
|
|
Senate Bill
|
1194
|
An Act relative to occupational presumption and COVID-19
|
Neutral
|
$0.00
|
n/a
|
| | | |
Total amount
|
$0.00
| |
|
|
Lobbyist: Dominique Salogar
|
|
Client:
Motion Picture Association, Inc.
|
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $0.00
|
|
Senate Bill
|
1983
|
An Act relative to the film tax credit
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
2491
|
An Act relative to 3D printed weapons and ghost guns
|
Neutral
|
$0.00
|
n/a
|
|
Senate Bill
|
1254
|
An Act relative to consumers and workers
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
136
|
An Act relative to data privacy
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
2875
|
An Act relative to increasing economic development and business opportunity in the design and manufacture of video games through the use of tax credits
|
Neutral
|
$0.00
|
n/a
|
|
Senate Bill
|
1619
|
An Act relative to the use of unmanned aerial systems
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
1504
|
An Act relative to strengthen the Commonwealth's Anti-SLAPP law
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
3733
|
An Act recognizing film production in Massachusetts
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
1452
|
An Act regarding asset forfeiture
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
3658
|
Resolutions for a United States constitutional amendment and a limited amendment proposing convention
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
2842
|
An Act to remove the film tax credit expiration date
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
1749
|
An Act for uniform fiduciary access to digital assets|
|
Neutral
|
$0.00
|
n/a
|
|
Senate Bill
|
919
|
An Act relative to protecting free speech through the anti-SLAPP law
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
1566
|
An Act relative to unmanned aerial vehicles
|
Neutral
|
$0.00
|
n/a
|
|
Senate Bill
|
46
|
An Act establishing the Massachusetts Information Privacy Act
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
585
|
An Act relative to student data privacy
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
3601
|
An Act relative to all-electronic tolling data privacy
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
688
|
An Act relative to media literacy in public schools
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
3609
|
An Act relative to unmanned aerial systems
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
144
|
Resolve establishing a special commission to review advancements in educational technology, digital/online learning and related programs
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
2928
|
An Act to establish a digital advertising revenue commission
|
Neutral
|
$0.00
|
n/a
|
|
Senate Bill
|
2200
|
An Act relative to digital entertainment on public rights of way
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
579
|
An Act to protect student privacy
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
3376
|
An Act relative to the use of elephants, big cats, primates, giraffes, and bears in traveling exhibits and shows
|
Neutral
|
$0.00
|
n/a
|
|
Senate Bill
|
1930
|
An Act supporting job growth in the Commonwealth
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
1755
|
An Act to protect against deep fakes used to facilitate criminal or torturous conduct
|
Neutral
|
$0.00
|
n/a
|
|
Senate Bill
|
1033
|
An Act relative to uniform fiduciary access to digital assets
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
130
|
An Act relative to a streaming entertainment operator’s use of the public rights-of-way
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
2842
|
An Act to remove the film tax credit expiration date
|
Neutral
|
$0.00
|
n/a
|
|
Senate Bill
|
1540
|
An Act relative to 3-D printed weapons and ghost guns
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
142
|
An Act establishing the Massachusetts information privacy act
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
2894
|
An Act relative to taxation of digital advertising services
|
Neutral
|
$0.00
|
n/a
|
|
Senate Bill
|
1983
|
An Act relative to the film tax credit
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
2910
|
An Act addressing COVID-19 impacts on film production in the Commonwealth
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
1783
|
An Act to ensure backyard privacy
|
Neutral
|
$0.00
|
n/a
|
|
Senate Bill
|
1241
|
An Act relative to consumers and workers
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
460
|
An Act relative to online advertising
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
3081
|
An Act establishing a tax on local revenues from digital advertising
|
Neutral
|
$0.00
|
n/a
|
|
Senate Bill
|
2251
|
An Act relative to the use of elephants, big cats, primates, giraffes, and bears in traveling exhibits and shows
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
1597
|
An Act relative to the Uniform Electronic Legal Material Act
|
Neutral
|
$0.00
|
n/a
|
|
Senate Bill
|
50
|
An Act relative to data security and privacy
|
Neutral
|
$0.00
|
n/a
|
| | | |
Total amount
|
$0.00
| |
|
|
Lobbyist: Dominique Salogar
|
|
Client:
Massachusetts State Automobile Dealers Association
|
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $0.00
|
|
Senate Bill
|
183
|
An Act further regulating business practices between motor vehicle dealers, manufacturers, and distributors
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
365
|
An Act relative to the right to repair motor vehicle data law
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
1070
|
An Act expanding automobile insurance coverage options to include the diminished value of automobiles
|
Neutral
|
$0.00
|
n/a
|
|
Senate Bill
|
657
|
An Act relative to motor vehicle service contracts
|
Neutral
|
$0.00
|
n/a
|
|
Senate Bill
|
234
|
An Act relative to the issuance of a class 1 dealer license
|
Neutral
|
$0.00
|
n/a
|
|
Senate Bill
|
719
|
An Act expanding automobile insurance coverage options to include the diminished value of automobiles
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
1152
|
An Act reforming labor rates paid by insurance companies to auto repairers in the Commonwealth
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
1183
|
An Act relative to motor vehicle service contracts
|
Neutral
|
$0.00
|
n/a
|
|
Senate Bill
|
711
|
An Act reforming labor rates paid by insurance companies to auto repairers in the Commonwealth
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
2004
|
An Act relative to commissioned employees
|
Neutral
|
$0.00
|
n/a
|
|
Senate Bill
|
239
|
An Act further regulating business practices between motor vehicle dealers, manufacturers, and distributors
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
407
|
An Act further regulating business practices between motor vehicle dealers, manufacturers, and distributors
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
336
|
An Act relative to the issuance of a class 1 dealer license
|
Neutral
|
$0.00
|
n/a
|
| | | |
Total amount
|
$0.00
| |
|
|
Lobbyist: Dominique Salogar
|
|
Client:
AstraZeneca Pharmaceuticals LP
|
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $0.00
|
|
Senate Bill
|
771
|
An Act relative to pharmaceutical access, costs and transparency
|
Oppose
|
$0.00
|
n/a
|
|
Executive
|
Other
|
Engaged in discussions with members of the Executive and Legislative branches concerning the development and potential rollout of AstraZeneca’s COVID-19 vaccine. As of the filing of this report, AstraZeneca’s vaccine has yet to be approved by the Food & Drug Administration (FDA). Thus, these discussions were for planning purposes only in the event the vaccine was approved. Specifically on COVID vaccine, members of the Legislative House COVID-19 Working Group. These topics pertained to the progress of clinical trials, distribution, and supply. Engaged on various COVID-19 current Executive Orders to ensure compliance with our essential workers in MA. Specifically Executive Order# 53 pertaining to stay-at-home advisory, business capacities and early closures and capacities (order #54) and face coverings (Order #55). Engaged in discussions related to the proposed rules for 101 CMR 801.00 and proposed drug pricing review regulations 958 CMR 12.00.
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
2377
|
An Act to permit the wholesale importation of prescription drugs into the Commonwealth
|
Oppose
|
$0.00
|
n/a
|
|
Senate Bill
|
696
|
An Act to help patients and reduce healthcare costs by ensuring patient adherence to medications
|
Support
|
$0.00
|
n/a
|
|
House Bill
|
1175
|
An Act relative to the diagnosis and treatment of breast cancer
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
1191
|
An Act to help patients and reduce health care costs by ensuring patient adherence to medications
|
Support
|
$0.00
|
n/a
|
|
Senate Bill
|
1915
|
An Act to eliminate the tax deduction for direct-to-consumer pharmaceutical marketing
|
Oppose
|
$0.00
|
n/a
|
|
House Bill
|
1
|
An Act making appropriations for the Fiscal Year 2022 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the Commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements
|
Oppose
|
$0.00
|
n/a
|
|
Senate Bill
|
728
|
An Act relative to pharmaceutical gag clauses
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
1311
|
An Act relative to step therapy and patient safety
|
Support
|
$0.00
|
n/a
|
|
House Bill
|
1247
|
An Act to ensure more affordable care
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
1201
|
An Act ensuring access to medications
|
Support
|
$0.00
|
n/a
|
|
Senate Bill
|
1480
|
An Act to prevent undue influence on prescriber behavior
|
Oppose
|
$0.00
|
n/a
|
|
House Bill
|
1237
|
An Act relative to non-medical switching
|
Support
|
$0.00
|
n/a
|
|
Senate Bill
|
1481
|
An Act to restore integrity in the marketing of pharmaceutical products and medical devices
|
Oppose
|
$0.00
|
n/a
|
|
Senate Bill
|
644
|
An Act relative to consumer deductibles
|
Support
|
$0.00
|
n/a
|
|
Senate Bill
|
790
|
An Act to define modest meals and refreshments in prescriber education settings
|
Oppose
|
$0.00
|
n/a
|
|
Senate Bill
|
808
|
An Act relative to cancer patient access to biomarker testing to provide appropriate therapy
|
Support
|
$0.00
|
n/a
|
|
Senate Bill
|
1465
|
An Act to reduce healthcare costs by promoting non-biased prescriber education
|
Oppose
|
$0.00
|
n/a
|
|
Senate Bill
|
3
|
An Act making appropriations for the fiscal year 2022 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Oppose
|
$0.00
|
n/a
|
|
Executive
|
Massachusetts Health Policy Commission (HPC)
|
Engaged in the Health Policy Commission (HPC) Drug Pricing Review Process and the Standard Reporting Form. Specifically the process for determining valuation of Rx drugs, transparency reporting requirements and rebate negotiations.
|
Oppose
|
$0.00
|
n/a
|
|
House Bill
|
1254
|
An Act relative to promoting comprehensive transparency in the pharmaceutical industry
|
Oppose
|
$0.00
|
n/a
|
|
Executive
|
Massachusetts Health Policy Commission (HPC)
|
Direct involvement with the State’s HPC as a formal member of the HPC Advisory Council in discussions to implement the MA Health Care Cost Containment Law (Chapter 224). Discussions with the HPC and/or Advisory Council and Center for Health Information & Analysis (CHIA) with a focus on health care price variation, gross and net Rx drug costs to the state, as well as the establishment and implementation of Accountable Care Organizations (ACO’s). My interactions are with HPC Board Members, HPC Staff to include Executive Director, and the staff from CHIA.
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
1053
|
An Act relative to consumer deductibles
|
Support
|
$0.00
|
n/a
|
|
Senate Bill
|
785
|
An Act to improve the accessibility and affordability of pharmaceutical drugs of public health concern
|
Oppose
|
$0.00
|
n/a
|
|
House Bill
|
4000
|
An Act making appropriations for the fiscal year 2022 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Oppose
|
$0.00
|
n/a
|
|
Executive
|
Massachusetts Health Policy Commission (HPC)
|
Promoted and assisted with information pertaining to the HPC study on the use of prescription drug coupons and vouchers. Interactions (virtual) with the HPC and participation in the HPC Advisory Council quarterly meetings (virtually). Participate in public meetings/discussions pertaining to drug costs (net and gross) and value-based contracts with health plans as well as MassHealth. Promoted the overall clinical value of prescription medicines and the economic impact of the biotechnology sector in the Commonwealth of MA.
|
Support
|
$0.00
|
n/a
|
|
House Bill
|
1137
|
An Act relative to cancer patient access to biomarker testing to provide appropriate therapy
|
Support
|
$0.00
|
n/a
|
|
Senate Bill
|
804
|
An Act to promote transparency and prevent price gouging of pharmaceutical drug prices
|
Oppose
|
$0.00
|
n/a
|
|
Senate Bill
|
756
|
An Act relative to step therapy and patient safety
|
Support
|
$0.00
|
n/a
|
|
Senate Bill
|
697
|
An Act relative to insurance coverage for mammograms and breast cancer screening
|
Neutral
|
$0.00
|
n/a
|
| | | |
Total amount
|
$0.00
| |
|
|
Lobbyist: Dominique Salogar
|
|
Client:
Sanofi US, Inc.
|
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $0.00
|
|
House Bill
|
1
|
An Act making appropriations for the Fiscal Year 2022 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the Commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements
|
Oppose
|
$0.00
|
n/a
|
|
Senate Bill
|
728
|
An Act relative to pharmaceutical gag clauses
|
Neutral
|
$0.00
|
n/a
|
|
Executive
|
Massachusetts Health Policy Commission (HPC)
|
Engaged in the Health Policy Commission (HPC) Drug Pricing Review Process and the Standard Reporting Form. Specifically the process for determining valuation of Rx drugs, transparency reporting requirements and rebate negotiations.
|
Oppose
|
$0.00
|
n/a
|
|
House Bill
|
4000
|
An Act making appropriations for the fiscal year 2022 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Oppose
|
$0.00
|
n/a
|
|
House Bill
|
1201
|
An Act ensuring access to medications
|
Support
|
$0.00
|
n/a
|
|
Senate Bill
|
808
|
An Act relative to cancer patient access to biomarker testing to provide appropriate therapy
|
Support
|
$0.00
|
n/a
|
|
Senate Bill
|
696
|
An Act to help patients and reduce healthcare costs by ensuring patient adherence to medications
|
Support
|
$0.00
|
n/a
|
|
House Bill
|
1175
|
An Act relative to the diagnosis and treatment of breast cancer
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
1237
|
An Act relative to non-medical switching
|
Support
|
$0.00
|
n/a
|
|
Senate Bill
|
1481
|
An Act to restore integrity in the marketing of pharmaceutical products and medical devices
|
Oppose
|
$0.00
|
n/a
|
|
Senate Bill
|
644
|
An Act relative to consumer deductibles
|
Support
|
$0.00
|
n/a
|
|
Senate Bill
|
790
|
An Act to define modest meals and refreshments in prescriber education settings
|
Oppose
|
$0.00
|
n/a
|
|
House Bill
|
1137
|
An Act relative to cancer patient access to biomarker testing to provide appropriate therapy
|
Support
|
$0.00
|
n/a
|
|
Senate Bill
|
804
|
An Act to promote transparency and prevent price gouging of pharmaceutical drug prices
|
Oppose
|
$0.00
|
n/a
|
|
Executive
|
Other
|
Engaged in discussions with members of the Executive and Legislative branches concerning the development and potential rollout of AstraZeneca’s COVID-19 vaccine. As of the filing of this report, AstraZeneca’s vaccine has yet to be approved by the Food & Drug Administration (FDA). Thus, these discussions were for planning purposes only in the event the vaccine was approved. Specifically on COVID vaccine, members of the Legislative House COVID-19 Working Group. These topics pertained to the progress of clinical trials, distribution, and supply. Engaged on various COVID-19 current Executive Orders to ensure compliance with our essential workers in MA. Specifically Executive Order# 53 pertaining to stay-at-home advisory, business capacities and early closures and capacities (order #54) and face coverings (Order #55). Engaged in discussions related to the proposed rules for 101 CMR 801.00 and proposed drug pricing review regulations 958 CMR 12.00.
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
1254
|
An Act relative to promoting comprehensive transparency in the pharmaceutical industry
|
Oppose
|
$0.00
|
n/a
|
|
House Bill
|
1053
|
An Act relative to consumer deductibles
|
Support
|
$0.00
|
n/a
|
|
Senate Bill
|
785
|
An Act to improve the accessibility and affordability of pharmaceutical drugs of public health concern
|
Oppose
|
$0.00
|
n/a
|
|
House Bill
|
1311
|
An Act relative to step therapy and patient safety
|
Support
|
$0.00
|
n/a
|
|
House Bill
|
1247
|
An Act to ensure more affordable care
|
Neutral
|
$0.00
|
n/a
|
|
Senate Bill
|
3
|
An Act making appropriations for the fiscal year 2022 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Oppose
|
$0.00
|
n/a
|
|
Executive
|
Massachusetts Health Policy Commission (HPC)
|
Promoted and assisted with information pertaining to the HPC study on the use of prescription drug coupons and vouchers. Interactions (virtual) with the HPC and participation in the HPC Advisory Council quarterly meetings (virtually). Participate in public meetings/discussions pertaining to drug costs (net and gross) and value-based contracts with health plans as well as MassHealth. Promoted the overall clinical value of prescription medicines and the economic impact of the biotechnology sector in the Commonwealth of MA.
|
Support
|
$0.00
|
n/a
|
|
Senate Bill
|
771
|
An Act relative to pharmaceutical access, costs and transparency
|
Oppose
|
$0.00
|
n/a
|
|
Senate Bill
|
756
|
An Act relative to step therapy and patient safety
|
Support
|
$0.00
|
n/a
|
|
Senate Bill
|
697
|
An Act relative to insurance coverage for mammograms and breast cancer screening
|
Neutral
|
$0.00
|
n/a
|
|
Executive
|
Massachusetts Health Policy Commission (HPC)
|
Direct involvement with the State’s HPC as a formal member of the HPC Advisory Council in discussions to implement the MA Health Care Cost Containment Law (Chapter 224). Discussions with the HPC and/or Advisory Council and Center for Health Information & Analysis (CHIA) with a focus on health care price variation, gross and net Rx drug costs to the state, as well as the establishment and implementation of Accountable Care Organizations (ACO’s). My interactions are with HPC Board Members, HPC Staff to include Executive Director, and the staff from CHIA.
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
2377
|
An Act to permit the wholesale importation of prescription drugs into the Commonwealth
|
Oppose
|
$0.00
|
n/a
|
|
Senate Bill
|
1465
|
An Act to reduce healthcare costs by promoting non-biased prescriber education
|
Oppose
|
$0.00
|
n/a
|
|
Senate Bill
|
1480
|
An Act to prevent undue influence on prescriber behavior
|
Oppose
|
$0.00
|
n/a
|
|
House Bill
|
1191
|
An Act to help patients and reduce health care costs by ensuring patient adherence to medications
|
Support
|
$0.00
|
n/a
|
|
Senate Bill
|
1915
|
An Act to eliminate the tax deduction for direct-to-consumer pharmaceutical marketing
|
Oppose
|
$0.00
|
n/a
|
| | | |
Total amount
|
$0.00
| |
|
|
Lobbyist: Dominique Salogar
|
|
Client:
Cape Cod Chamber of Commerce & CVB
|
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $0.00
|
|
House Docket
|
401
|
Timily - allocation of funds
|
Support
|
$0.00
|
n/a
|
|
House Docket
|
1336
|
Tom Walsh - administrative costs
|
Support
|
$0.00
|
n/a
|
|
Senate Docket
|
1792
|
Timily - allocation of funds
|
Support
|
$0.00
|
n/a
|
|
Senate Docket
|
1792
|
Tourism recovery
|
Support
|
$0.00
|
n/a
|
| | | |
Total amount
|
$0.00
| |
|
|
|
|
Meals, Travel, and Entertainment Expenses
|
| No meals, travel, or entertainment expenses were filed for this disclosure reporting period. |
|
| |
|
Additional Expenses
|
| No additional expenses were filed for this disclosure reporting period. |
|
| |
|
Campaign Contributions
|
| 01/01/2021 | Dominique Salogar |
Marjorie Decker
|
State Representative
|
$50.00
|
| 05/18/2021 | Dominique Salogar |
Barry Finegold
|
State Senate
|
$200.00
|
| 05/25/2021 | Dominique Salogar |
Kate Hogan
|
State Representative
|
$200.00
|
| | | | Total contributions |
$450.00
|
|
|
Lobbyist: Martin G. Corry
|
|
Client:
Beer Distributors of Massachusetts, Inc.
|
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $0.00
|
|
House Docket
|
320
|
An Act to Promote Alcohol Storage Space
|
Neutral
|
$0.00
|
n/a
|
|
Senate Bill
|
2159
|
An Act relative to the proper disposal of miniatures
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
343
|
An Act relative to the sale of liquor licenses
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
318
|
An Act relative to the sale of wines and malt beverages by food stores
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
373
|
An Act relative to notification of alcohol by volume in beers to be consumed on the premises
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
362
|
An Act relative to alcoholic beverage containers
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
26
|
An Act modernizing the Massachusetts alcohol laws
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
315
|
An Act relative to municipal millennials
|
Neutral
|
$0.00
|
n/a
|
|
Senate Bill
|
179
|
An Act to update the alcohol excise tax
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
334
|
An Act relative to the registration of veterinarians
|
Neutral
|
$0.00
|
n/a
|
|
Senate Bill
|
168
|
An Act relative to the creation of additional business opportunities for alcohol retailers
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
374
|
An Act for all licensees for beer to be drunk on the premises must list the alcohol by volume for each beer selection on the menu
|
Neutral
|
$0.00
|
n/a
|
|
Senate Bill
|
2215
|
An Act to create a deposit for glass wine and liquor bottles
|
Neutral
|
$0.00
|
n/a
|
|
Senate Bill
|
1921
|
An Act relative to the taxation of cider
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
397
|
An Act expanding access to craft beer
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
338
|
An Act further regulating storage of alcoholic beverages
|
Neutral
|
$0.00
|
n/a
|
|
Senate Bill
|
169
|
An Act restoring happy hour to the commonwealth
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
364
|
An Act relative to the sale of alcoholic beverages
|
Neutral
|
$0.00
|
n/a
|
| | | |
Total amount
|
$0.00
| |
|
|
Lobbyist: Martin G. Corry
|
|
Client:
Coalition of Families and Advocates - COFAR
|
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $0.00
|
|
Senate Bill
|
1257
|
An Act establishing a commission on the history of state institutions for people with developmental and mental health disabilities in the Commonwealth
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
2090
|
An Act establishing a special commission to study and report on the history of state institutions for people with developmental and mental health disabilities in the Commonwealth
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
193
|
An Act regarding transparency for individuals and guardians
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
1733
|
An Act further regulating the appointment of certain guardians
|
Neutral
|
$0.00
|
n/a
|
| | | |
Total amount
|
$0.00
| |
|
|
Lobbyist: Martin G. Corry
|
|
Client:
Massachusetts Nurses Association
|
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $0.00
|
|
House Bill
|
2465
|
An Act requiring health care employers to develop and implement programs to prevent workplace violence
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
1253
|
An Act relative to the closing of hospital essential services
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
1888
|
An Act relative to strengthening the penalty for assault or assault and battery on an emergency medical technician, ambulance operator, ambulance attendant or health care provider
|
Neutral
|
$0.00
|
n/a
|
|
Senate Bill
|
1603
|
An Act requiring health care facilities to develop and implement programs to prevent workplace violence
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
496
|
An Act relative to PPE data transparency
|
Neutral
|
$0.00
|
n/a
|
|
Senate Bill
|
1194
|
An Act relative to occupational presumption and COVID-19
|
Neutral
|
$0.00
|
n/a
|
|
Senate Bill
|
1310
|
An Act relative to creating intensive stabilization and treatment units within the Department of Mental Health
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
2249
|
An Act relative to safe patient handling and mobility in certain health facilities
|
Neutral
|
$0.00
|
n/a
|
|
Senate Bill
|
754
|
An Act relative to the closing of hospital essential services
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
2706
|
An Act relative to credible service for school nurses
|
Neutral
|
$0.00
|
n/a
|
|
Senate Bill
|
253
|
An Act relative to PPE data transparency
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
1255
|
An Act relative to hospital profit transparency and fairness
|
Neutral
|
$0.00
|
n/a
|
| | | |
Total amount
|
$0.00
| |
|
|
Lobbyist: Martin G. Corry
|
|
Client:
Motion Picture Association, Inc.
|
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $0.00
|
|
House Bill
|
579
|
An Act to protect student privacy
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
3376
|
An Act relative to the use of elephants, big cats, primates, giraffes, and bears in traveling exhibits and shows
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
688
|
An Act relative to media literacy in public schools
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
3609
|
An Act relative to unmanned aerial systems
|
Neutral
|
$0.00
|
n/a
|
|
Senate Bill
|
1983
|
An Act relative to the film tax credit
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
2491
|
An Act relative to 3D printed weapons and ghost guns
|
Neutral
|
$0.00
|
n/a
|
|
Senate Bill
|
1254
|
An Act relative to consumers and workers
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
2910
|
An Act addressing COVID-19 impacts on film production in the Commonwealth
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
1783
|
An Act to ensure backyard privacy
|
Neutral
|
$0.00
|
n/a
|
|
Senate Bill
|
1241
|
An Act relative to consumers and workers
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
142
|
An Act establishing the Massachusetts information privacy act
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
2894
|
An Act relative to taxation of digital advertising services
|
Neutral
|
$0.00
|
n/a
|
|
Senate Bill
|
1983
|
An Act relative to the film tax credit
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
130
|
An Act relative to a streaming entertainment operator’s use of the public rights-of-way
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
2842
|
An Act to remove the film tax credit expiration date
|
Support
|
$0.00
|
n/a
|
|
Senate Bill
|
1540
|
An Act relative to 3-D printed weapons and ghost guns
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
2842
|
An Act to remove the film tax credit expiration date
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
1749
|
An Act for uniform fiduciary access to digital assets|
|
Neutral
|
$0.00
|
n/a
|
|
Senate Bill
|
919
|
An Act relative to protecting free speech through the anti-SLAPP law
|
Neutral
|
$0.00
|
n/a
|
|
Senate Bill
|
1930
|
An Act supporting job growth in the Commonwealth
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
1755
|
An Act to protect against deep fakes used to facilitate criminal or torturous conduct
|
Neutral
|
$0.00
|
n/a
|
|
Senate Bill
|
1033
|
An Act relative to uniform fiduciary access to digital assets
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
1504
|
An Act relative to strengthen the Commonwealth's Anti-SLAPP law
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
3733
|
An Act recognizing film production in Massachusetts
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
1597
|
An Act relative to the Uniform Electronic Legal Material Act
|
Neutral
|
$0.00
|
n/a
|
|
Senate Bill
|
50
|
An Act relative to data security and privacy
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
144
|
Resolve establishing a special commission to review advancements in educational technology, digital/online learning and related programs
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
2928
|
An Act to establish a digital advertising revenue commission
|
Neutral
|
$0.00
|
n/a
|
|
Senate Bill
|
2200
|
An Act relative to digital entertainment on public rights of way
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
585
|
An Act relative to student data privacy
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
3601
|
An Act relative to all-electronic tolling data privacy
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
1452
|
An Act regarding asset forfeiture
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
3658
|
Resolutions for a United States constitutional amendment and a limited amendment proposing convention
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
460
|
An Act relative to online advertising
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
3081
|
An Act establishing a tax on local revenues from digital advertising
|
Neutral
|
$0.00
|
n/a
|
|
Senate Bill
|
2251
|
An Act relative to the use of elephants, big cats, primates, giraffes, and bears in traveling exhibits and shows
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
1566
|
An Act relative to unmanned aerial vehicles
|
Neutral
|
$0.00
|
n/a
|
|
Senate Bill
|
46
|
An Act establishing the Massachusetts Information Privacy Act
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
136
|
An Act relative to data privacy
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
2875
|
An Act relative to increasing economic development and business opportunity in the design and manufacture of video games through the use of tax credits
|
Neutral
|
$0.00
|
n/a
|
|
Senate Bill
|
1619
|
An Act relative to the use of unmanned aerial systems
|
Neutral
|
$0.00
|
n/a
|
| | | |
Total amount
|
$0.00
| |
|
|
Lobbyist: Martin G. Corry
|
|
Client:
Massachusetts State Automobile Dealers Association
|
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $0.00
|
|
House Bill
|
1152
|
An Act reforming labor rates paid by insurance companies to auto repairers in the Commonwealth
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
1070
|
An Act expanding automobile insurance coverage options to include the diminished value of automobiles
|
Neutral
|
$0.00
|
n/a
|
|
Senate Bill
|
183
|
An Act further regulating business practices between motor vehicle dealers, manufacturers, and distributors
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
407
|
An Act further regulating business practices between motor vehicle dealers, manufacturers, and distributors
|
Neutral
|
$0.00
|
n/a
|
|
Senate Bill
|
239
|
An Act further regulating business practices between motor vehicle dealers, manufacturers, and distributors
|
Neutral
|
$0.00
|
n/a
|
|
Senate Bill
|
234
|
An Act relative to the issuance of a class 1 dealer license
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
2004
|
An Act relative to commissioned employees
|
Neutral
|
$0.00
|
n/a
|
|
Senate Bill
|
657
|
An Act relative to motor vehicle service contracts
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
336
|
An Act relative to the issuance of a class 1 dealer license
|
Neutral
|
$0.00
|
n/a
|
|
Senate Bill
|
711
|
An Act reforming labor rates paid by insurance companies to auto repairers in the Commonwealth
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
1183
|
An Act relative to motor vehicle service contracts
|
Neutral
|
$0.00
|
n/a
|
|
Senate Bill
|
719
|
An Act expanding automobile insurance coverage options to include the diminished value of automobiles
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
365
|
An Act relative to the right to repair motor vehicle data law
|
Neutral
|
$0.00
|
n/a
|
| | | |
Total amount
|
$0.00
| |
|
|
Lobbyist: Martin G. Corry
|
|
Client:
Sanofi US, Inc.
|
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $0.00
|
|
House Bill
|
1237
|
An Act relative to non-medical switching
|
Support
|
$0.00
|
n/a
|
|
Senate Bill
|
1465
|
An Act to reduce healthcare costs by promoting non-biased prescriber education
|
Oppose
|
$0.00
|
n/a
|
|
House Bill
|
1311
|
An Act relative to step therapy and patient safety
|
Support
|
$0.00
|
n/a
|
|
Senate Bill
|
1481
|
An Act to restore integrity in the marketing of pharmaceutical products and medical devices
|
Oppose
|
$0.00
|
n/a
|
|
Senate Bill
|
771
|
An Act relative to pharmaceutical access, costs and transparency
|
Oppose
|
$0.00
|
n/a
|
|
Executive
|
Other
|
Engaged in discussions with members of the Executive and Legislative branches concerning the development and potential rollout of AstraZeneca’s COVID-19 vaccine. As of the filing of this report, AstraZeneca’s vaccine has yet to be approved by the Food & Drug Administration (FDA). Thus, these discussions were for planning purposes only in the event the vaccine was approved. Specifically on COVID vaccine, members of the Legislative House COVID-19 Working Group. These topics pertained to the progress of clinical trials, distribution, and supply. Engaged on various COVID-19 current Executive Orders to ensure compliance with our essential workers in MA. Specifically Executive Order# 53 pertaining to stay-at-home advisory, business capacities and early closures and capacities (order #54) and face coverings (Order #55). Engaged in discussions related to the proposed rules for 101 CMR 801.00 and proposed drug pricing review regulations 958 CMR 12.00.
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
4000
|
An Act making appropriations for the fiscal year 2022 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Oppose
|
$0.00
|
n/a
|
|
Executive
|
Massachusetts Health Policy Commission (HPC)
|
Promoted and assisted with information pertaining to the HPC study on the use of prescription drug coupons and vouchers. Interactions (virtual) with the HPC and participation in the HPC Advisory Council quarterly meetings (virtually). Participate in public meetings/discussions pertaining to drug costs (net and gross) and value-based contracts with health plans as well as MassHealth. Promoted the overall clinical value of prescription medicines and the economic impact of the biotechnology sector in the Commonwealth of MA.
|
Support
|
$0.00
|
n/a
|
|
House Bill
|
1053
|
An Act relative to consumer deductibles
|
Support
|
$0.00
|
n/a
|
|
Senate Bill
|
785
|
An Act to improve the accessibility and affordability of pharmaceutical drugs of public health concern
|
Oppose
|
$0.00
|
n/a
|
|
House Bill
|
1254
|
An Act relative to promoting comprehensive transparency in the pharmaceutical industry
|
Oppose
|
$0.00
|
n/a
|
|
Executive
|
Massachusetts Health Policy Commission (HPC)
|
Direct involvement with the State’s HPC as a formal member of the HPC Advisory Council in discussions to implement the MA Health Care Cost Containment Law (Chapter 224). Discussions with the HPC and/or Advisory Council and Center for Health Information & Analysis (CHIA) with a focus on health care price variation, gross and net Rx drug costs to the state, as well as the establishment and implementation of Accountable Care Organizations (ACO’s). My interactions are with HPC Board Members, HPC Staff to include Executive Director, and the staff from CHIA.
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
1
|
An Act making appropriations for the Fiscal Year 2022 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the Commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements
|
Oppose
|
$0.00
|
n/a
|
|
Senate Bill
|
728
|
An Act relative to pharmaceutical gag clauses
|
Neutral
|
$0.00
|
n/a
|
|
Senate Bill
|
3
|
An Act making appropriations for the fiscal year 2022 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Oppose
|
$0.00
|
n/a
|
|
Executive
|
Massachusetts Health Policy Commission (HPC)
|
Engaged in the Health Policy Commission (HPC) Drug Pricing Review Process and the Standard Reporting Form. Specifically the process for determining valuation of Rx drugs, transparency reporting requirements and rebate negotiations.
|
Oppose
|
$0.00
|
n/a
|
|
Senate Bill
|
808
|
An Act relative to cancer patient access to biomarker testing to provide appropriate therapy
|
Support
|
$0.00
|
n/a
|
|
House Bill
|
1175
|
An Act relative to the diagnosis and treatment of breast cancer
|
Neutral
|
$0.00
|
n/a
|
|
Senate Bill
|
756
|
An Act relative to step therapy and patient safety
|
Support
|
$0.00
|
n/a
|
|
Senate Bill
|
697
|
An Act relative to insurance coverage for mammograms and breast cancer screening
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
1137
|
An Act relative to cancer patient access to biomarker testing to provide appropriate therapy
|
Support
|
$0.00
|
n/a
|
|
Senate Bill
|
790
|
An Act to define modest meals and refreshments in prescriber education settings
|
Oppose
|
$0.00
|
n/a
|
|
House Bill
|
1191
|
An Act to help patients and reduce health care costs by ensuring patient adherence to medications
|
Support
|
$0.00
|
n/a
|
|
Senate Bill
|
1480
|
An Act to prevent undue influence on prescriber behavior
|
Oppose
|
$0.00
|
n/a
|
|
Senate Bill
|
644
|
An Act relative to consumer deductibles
|
Support
|
$0.00
|
n/a
|
|
Senate Bill
|
1915
|
An Act to eliminate the tax deduction for direct-to-consumer pharmaceutical marketing
|
Oppose
|
$0.00
|
n/a
|
|
House Bill
|
1201
|
An Act ensuring access to medications
|
Support
|
$0.00
|
n/a
|
|
Senate Bill
|
804
|
An Act to promote transparency and prevent price gouging of pharmaceutical drug prices
|
Oppose
|
$0.00
|
n/a
|
|
Senate Bill
|
696
|
An Act to help patients and reduce healthcare costs by ensuring patient adherence to medications
|
Support
|
$0.00
|
n/a
|
|
House Bill
|
1247
|
An Act to ensure more affordable care
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
2377
|
An Act to permit the wholesale importation of prescription drugs into the Commonwealth
|
Oppose
|
$0.00
|
n/a
|
| | | |
Total amount
|
$0.00
| |
|
|
Lobbyist: Martin G. Corry
|
|
Client:
AstraZeneca Pharmaceuticals LP
|
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $0.00
|
|
House Bill
|
1201
|
An Act ensuring access to medications
|
Support
|
$0.00
|
n/a
|
|
Senate Bill
|
1480
|
An Act to prevent undue influence on prescriber behavior
|
Oppose
|
$0.00
|
n/a
|
|
House Bill
|
1191
|
An Act to help patients and reduce health care costs by ensuring patient adherence to medications
|
Support
|
$0.00
|
n/a
|
|
Senate Bill
|
1915
|
An Act to eliminate the tax deduction for direct-to-consumer pharmaceutical marketing
|
Oppose
|
$0.00
|
n/a
|
|
House Bill
|
1254
|
An Act relative to promoting comprehensive transparency in the pharmaceutical industry
|
Oppose
|
$0.00
|
n/a
|
|
Executive
|
Massachusetts Health Policy Commission (HPC)
|
Direct involvement with the State’s HPC as a formal member of the HPC Advisory Council in discussions to implement the MA Health Care Cost Containment Law (Chapter 224). Discussions with the HPC and/or Advisory Council and Center for Health Information & Analysis (CHIA) with a focus on health care price variation, gross and net Rx drug costs to the state, as well as the establishment and implementation of Accountable Care Organizations (ACO’s). My interactions are with HPC Board Members, HPC Staff to include Executive Director, and the staff from CHIA.
|
Neutral
|
$0.00
|
n/a
|
|
Senate Bill
|
771
|
An Act relative to pharmaceutical access, costs and transparency
|
Oppose
|
$0.00
|
n/a
|
|
Executive
|
Other
|
Engaged in discussions with members of the Executive and Legislative branches concerning the development and potential rollout of AstraZeneca’s COVID-19 vaccine. As of the filing of this report, AstraZeneca’s vaccine has yet to be approved by the Food & Drug Administration (FDA). Thus, these discussions were for planning purposes only in the event the vaccine was approved. Specifically on COVID vaccine, members of the Legislative House COVID-19 Working Group. These topics pertained to the progress of clinical trials, distribution, and supply. Engaged on various COVID-19 current Executive Orders to ensure compliance with our essential workers in MA. Specifically Executive Order# 53 pertaining to stay-at-home advisory, business capacities and early closures and capacities (order #54) and face coverings (Order #55). Engaged in discussions related to the proposed rules for 101 CMR 801.00 and proposed drug pricing review regulations 958 CMR 12.00.
|
Neutral
|
$0.00
|
n/a
|
|
Senate Bill
|
644
|
An Act relative to consumer deductibles
|
Support
|
$0.00
|
n/a
|
|
Senate Bill
|
790
|
An Act to define modest meals and refreshments in prescriber education settings
|
Oppose
|
$0.00
|
n/a
|
|
House Bill
|
2377
|
An Act to permit the wholesale importation of prescription drugs into the Commonwealth
|
Oppose
|
$0.00
|
n/a
|
|
House Bill
|
4000
|
An Act making appropriations for the fiscal year 2022 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Oppose
|
$0.00
|
n/a
|
|
Executive
|
Massachusetts Health Policy Commission (HPC)
|
Engaged in the Health Policy Commission (HPC) Drug Pricing Review Process and the Standard Reporting Form. Specifically the process for determining valuation of Rx drugs, transparency reporting requirements and rebate negotiations.
|
Oppose
|
$0.00
|
n/a
|
|
Senate Bill
|
3
|
An Act making appropriations for the fiscal year 2022 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Oppose
|
$0.00
|
n/a
|
|
Executive
|
Massachusetts Health Policy Commission (HPC)
|
Promoted and assisted with information pertaining to the HPC study on the use of prescription drug coupons and vouchers. Interactions (virtual) with the HPC and participation in the HPC Advisory Council quarterly meetings (virtually). Participate in public meetings/discussions pertaining to drug costs (net and gross) and value-based contracts with health plans as well as MassHealth. Promoted the overall clinical value of prescription medicines and the economic impact of the biotechnology sector in the Commonwealth of MA.
|
Support
|
$0.00
|
n/a
|
|
House Bill
|
1311
|
An Act relative to step therapy and patient safety
|
Support
|
$0.00
|
n/a
|
|
House Bill
|
1247
|
An Act to ensure more affordable care
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
1
|
An Act making appropriations for the Fiscal Year 2022 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the Commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements
|
Oppose
|
$0.00
|
n/a
|
|
Senate Bill
|
728
|
An Act relative to pharmaceutical gag clauses
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
1137
|
An Act relative to cancer patient access to biomarker testing to provide appropriate therapy
|
Support
|
$0.00
|
n/a
|
|
Senate Bill
|
804
|
An Act to promote transparency and prevent price gouging of pharmaceutical drug prices
|
Oppose
|
$0.00
|
n/a
|
|
House Bill
|
1237
|
An Act relative to non-medical switching
|
Support
|
$0.00
|
n/a
|
|
Senate Bill
|
1481
|
An Act to restore integrity in the marketing of pharmaceutical products and medical devices
|
Oppose
|
$0.00
|
n/a
|
|
Senate Bill
|
696
|
An Act to help patients and reduce healthcare costs by ensuring patient adherence to medications
|
Support
|
$0.00
|
n/a
|
|
House Bill
|
1175
|
An Act relative to the diagnosis and treatment of breast cancer
|
Neutral
|
$0.00
|
n/a
|
|
Senate Bill
|
808
|
An Act relative to cancer patient access to biomarker testing to provide appropriate therapy
|
Support
|
$0.00
|
n/a
|
|
Senate Bill
|
1465
|
An Act to reduce healthcare costs by promoting non-biased prescriber education
|
Oppose
|
$0.00
|
n/a
|
|
Senate Bill
|
756
|
An Act relative to step therapy and patient safety
|
Support
|
$0.00
|
n/a
|
|
Senate Bill
|
697
|
An Act relative to insurance coverage for mammograms and breast cancer screening
|
Neutral
|
$0.00
|
n/a
|
|
House Bill
|
1053
|
An Act relative to consumer deductibles
|
Support
|
$0.00
|
n/a
|
|
Senate Bill
|
785
|
An Act to improve the accessibility and affordability of pharmaceutical drugs of public health concern
|
Oppose
|
$0.00
|
n/a
|
| | | |
Total amount
|
$0.00
| |
|
|
Lobbyist: Martin G. Corry
|
|
Client:
Cape Cod Chamber of Commerce & CVB
|
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $0.00
|
|
Senate Docket
|
1792
|
Timily allocation of funds
|
Support
|
$0.00
|
n/a
|
|
House Docket
|
1336
|
Administrative costs
|
Support
|
$0.00
|
n/a
|
|
Senate Docket
|
1803
|
Tourism recovery
|
Support
|
$0.00
|
n/a
|
|
House Docket
|
401
|
Tucker - allocation of funds
|
Support
|
$0.00
|
n/a
|
| | | |
Total amount
|
$0.00
| |
|
|
|
|
Meals, Travel, and Entertainment Expenses
|
| No meals, travel, or entertainment expenses were filed for this disclosure reporting period. |
|
| |
|
Additional Expenses
|
| No additional expenses were filed for this disclosure reporting period. |
|
| |
|
Campaign Contributions
|
| 01/28/2021 | Martin G. Corry |
Juan Pablo Jaramillo
|
Committee to elect Juan Pablo Jaramillo, State Rep
|
$200.00
|
| 02/19/2021 | Martin G. Corry |
Jon Santiago
|
Representative
|
$200.00
|
| 02/23/2021 | Martin G. Corry |
Michael J Rodrigues
|
Senate
|
$200.00
|
| 02/25/2021 | Martin G. Corry |
Bryan Barash
|
Newton City Council
|
$200.00
|
| 03/04/2021 | Martin G. Corry |
Orlando Ramos
|
Representative
|
$200.00
|
| 03/06/2021 | Martin G. Corry |
Jeffrey Turco
|
Representative
|
$200.00
|
| 03/06/2021 | Martin G. Corry |
Eric Lesser
|
Senate
|
$200.00
|
| 03/10/2021 | Martin G. Corry |
David Biele
|
Representative
|
$200.00
|
| 03/12/2021 | Martin G. Corry |
Katherine Clark
|
Representative
|
$200.00
|
| 03/13/2021 | Martin G. Corry |
Adrian Madaro
|
Representative
|
$200.00
|
| 03/13/2021 | Martin G. Corry |
Michael Rush
|
Senate
|
$200.00
|
| 03/17/2021 | Martin G. Corry |
Jessica Giannino
|
Representative
|
$200.00
|
| 03/28/2021 | Martin G. Corry |
Michael Moore
|
Senate
|
$200.00
|
| 03/29/2021 | Martin G. Corry |
Nick Collins
|
Senate
|
$200.00
|
| 03/31/2021 | Martin G. Corry |
Josh Cutler
|
Representative
|
$200.00
|
| 03/31/2021 | Martin G. Corry |
Marjorie Decker
|
Representative
|
$200.00
|
| 03/31/2021 | Martin G. Corry |
Diane DiZoglio
|
Representative
|
$200.00
|
| 04/27/2021 | Martin G. Corry |
Adam Hinds
|
Senate
|
$200.00
|
| 05/05/2021 | Martin G. Corry |
John Velis
|
Senate
|
$200.00
|
| 05/12/2021 | Martin G. Corry |
Brendan Crighton
|
Senate
|
$200.00
|
| 05/19/2021 | Martin G. Corry |
Erin Murphy
|
Boston City Council
|
$200.00
|
| 05/25/2021 | Martin G. Corry |
Kate Hogan
|
Representative
|
$200.00
|
| 05/27/2021 | Martin G. Corry |
Ed Coppinger
|
Representative
|
$200.00
|
| 06/03/2021 | Martin G. Corry |
Sal DiDomenico
|
Senate
|
$200.00
|
| 06/15/2021 | Martin G. Corry |
Jerry Parisella
|
Representative
|
$200.00
|
| | | | Total contributions |
$5,000.00
|
|
|
|
|
|